Abstract
Despite radical chemo-radiotherapy (CRT), many patients with intermediate and high risk SCC oropharynx (OPSCC) relapse. Treatment related toxicity limits further uniform intensification across the patient group. If a predictive biomarker for outcomes from CRT can be identified during treatment, individualised and adaptive treatment strategies may be employed for the non-responders. This is the 1st study to use DW MRI for early response assessment in a specific H&N sub-site with sub-type of similar biological behaviour.
Original language | English |
---|---|
Pages (from-to) | S631-S632 |
Number of pages | 2 |
Journal | Radiotherapy and Oncology |
Volume | 133 |
DOIs | |
Publication status | Published - 30 Apr 2019 |
Event | The European Society for Radiotherapy and Oncology Conference 38 - Milan, Italy Duration: 26 Apr 2018 → 30 Apr 2019 https://www.estro.org/congresses-meetings/items/estro-38 |
Keywords
- EP-1137
- DW MRI
- biomarker
- response
- RT
- intermed/high risk SCC oropharynx
- feasibility study